Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10663979rdf:typepubmed:Citationlld:pubmed
pubmed-article:10663979lifeskim:mentionsumls-concept:C0030664lld:lifeskim
pubmed-article:10663979lifeskim:mentionsumls-concept:C0085200lld:lifeskim
pubmed-article:10663979lifeskim:mentionsumls-concept:C0018523lld:lifeskim
pubmed-article:10663979lifeskim:mentionsumls-concept:C0338473lld:lifeskim
pubmed-article:10663979lifeskim:mentionsumls-concept:C0205219lld:lifeskim
pubmed-article:10663979lifeskim:mentionsumls-concept:C1842069lld:lifeskim
pubmed-article:10663979lifeskim:mentionsumls-concept:C0205246lld:lifeskim
pubmed-article:10663979pubmed:issue3lld:pubmed
pubmed-article:10663979pubmed:dateCreated2000-5-23lld:pubmed
pubmed-article:10663979pubmed:abstractTextWe describe an unusual case of Hallervorden-Spatz disease (HSD). After presenting with limb rigidospasticity at the age of 9 years, our patient developed progressive dementia, spastic tetraparesis and myoclonic movements, leading to akinetic mutism. He died of pneumonia at the age of 39 years. Autopsy revealed a severely atrophic brain, weighing 510 g. Histologically, there were iron deposits in the globus pallidus and substantia nigra pars reticulata, and numerous axonal spheroids throughout the brain and spinal cord. Neurofibrillary tangles were abundant in the hippocampus, cerebral neocortex, basal ganglia and brain stem. Neuritic plaques and amyloid deposits were absent. Lewy bodies and Lewy neurites, which were immunolabeled by anti-alpha-synuclein, were found in the brain stem, cerebral cortex and spinal gray matter. Sarkosyl-insoluble tau extracted from the temporal cortex resolved on immunoblots into three major bands of 60, 64 and 68 kDa and a minor band of 72 kDa, as reported for Alzheimer's disease. The present case, together with a few similar cases reported previously, may represent a particular subset of neuroaxonal dystrophy, i.e., HSD associated with extensive accumulation of both tau and alpha-synuclein.lld:pubmed
pubmed-article:10663979pubmed:languageenglld:pubmed
pubmed-article:10663979pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10663979pubmed:citationSubsetIMlld:pubmed
pubmed-article:10663979pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10663979pubmed:statusMEDLINElld:pubmed
pubmed-article:10663979pubmed:monthMarlld:pubmed
pubmed-article:10663979pubmed:issn0001-6322lld:pubmed
pubmed-article:10663979pubmed:authorpubmed-author:FukushimaTTlld:pubmed
pubmed-article:10663979pubmed:authorpubmed-author:NodaTTlld:pubmed
pubmed-article:10663979pubmed:authorpubmed-author:HorikawaYYlld:pubmed
pubmed-article:10663979pubmed:authorpubmed-author:WatanabeYYlld:pubmed
pubmed-article:10663979pubmed:authorpubmed-author:WakabayashiKKlld:pubmed
pubmed-article:10663979pubmed:authorpubmed-author:TakahashiHHlld:pubmed
pubmed-article:10663979pubmed:authorpubmed-author:YoshimotoMMlld:pubmed
pubmed-article:10663979pubmed:authorpubmed-author:MoritzMMlld:pubmed
pubmed-article:10663979pubmed:authorpubmed-author:HasegawaMMlld:pubmed
pubmed-article:10663979pubmed:authorpubmed-author:KoideRRlld:pubmed
pubmed-article:10663979pubmed:authorpubmed-author:IwatsuboTTlld:pubmed
pubmed-article:10663979pubmed:authorpubmed-author:EguchiIIlld:pubmed
pubmed-article:10663979pubmed:issnTypePrintlld:pubmed
pubmed-article:10663979pubmed:volume99lld:pubmed
pubmed-article:10663979pubmed:ownerNLMlld:pubmed
pubmed-article:10663979pubmed:authorsCompleteYlld:pubmed
pubmed-article:10663979pubmed:pagination331-6lld:pubmed
pubmed-article:10663979pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:10663979pubmed:meshHeadingpubmed-meshheading:10663979...lld:pubmed
pubmed-article:10663979pubmed:meshHeadingpubmed-meshheading:10663979...lld:pubmed
pubmed-article:10663979pubmed:meshHeadingpubmed-meshheading:10663979...lld:pubmed
pubmed-article:10663979pubmed:meshHeadingpubmed-meshheading:10663979...lld:pubmed
pubmed-article:10663979pubmed:meshHeadingpubmed-meshheading:10663979...lld:pubmed
pubmed-article:10663979pubmed:meshHeadingpubmed-meshheading:10663979...lld:pubmed
pubmed-article:10663979pubmed:meshHeadingpubmed-meshheading:10663979...lld:pubmed
pubmed-article:10663979pubmed:meshHeadingpubmed-meshheading:10663979...lld:pubmed
pubmed-article:10663979pubmed:meshHeadingpubmed-meshheading:10663979...lld:pubmed
pubmed-article:10663979pubmed:meshHeadingpubmed-meshheading:10663979...lld:pubmed
pubmed-article:10663979pubmed:meshHeadingpubmed-meshheading:10663979...lld:pubmed
pubmed-article:10663979pubmed:year2000lld:pubmed
pubmed-article:10663979pubmed:articleTitleJuvenile-onset generalized neuroaxonal dystrophy (Hallervorden-Spatz disease) with diffuse neurofibrillary and lewy body pathology.lld:pubmed
pubmed-article:10663979pubmed:affiliationBrain Disease Research Center, Brain Research Institute, Niigata University, 1 Asahimachi, Niigata 951-8585, Japan. koichi@bri.niigata-u.ac.jplld:pubmed
pubmed-article:10663979pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10663979pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:10663979pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10663979lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10663979lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10663979lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10663979lld:pubmed